Avadel Pharmaceuticals plc: Disclosure of Voting Rights under Derivatives
ByAinvest
Thursday, Jan 29, 2026 9:00 am ET1min read
AVDL--
Avadel Pharmaceuticals has received a notification from Bloomberg regarding a Form 8.3 submission. The notification does not provide further details about the submission, but it appears to be related to voting rights or the acquisition/disposal of relevant securities. Bloomberg is a leading provider of financial data and analytics, and the notification may indicate a change in ownership or trading activity related to Avadel Pharmaceuticals.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet